GETI-B:STO
Getinge publ AB
250,80Â SEK
arrow_upward
+0,08%(+0,20) 1K
7-okt, 14:23:35 (GMT+2) · SEK
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoGETI-B tikeri uchun statistika yaratilmoqda...
Ochish
250,40Â SEK
Yuqori
252,30Â SEK
Past
249,70Â SEK
Bozor kapitali
62,83Â mlrd
Oʻrtacha hajm
578,49Â ming
Hajmi
117,35Â ming
Dividend
1,89%
Choraklik dividendlar
1,19Â SEK
Eks-dividend sanasi
22-apr, 2026
P/E koeffitsiyenti
25,55
52 haftalik eng yuqori
252,30Â SEK
52 haftalik eng past
175,90Â SEK
Aksiya boʻyicha daromad
9,82Â SEK
Muomaladagi aksiyalar
254,15Â mln
Xodimlar soni
12Â ming
Ochish
250,40Â SEK
Yuqori
252,30Â SEK
Past
249,70Â SEK
Bozor kapitali
62,83Â mlrd
Oʻrtacha hajm
578,49Â ming
Hajmi
117,35Â ming
Dividend
1,89%
Choraklik dividendlar
1,19Â SEK
Eks-dividend sanasi
22-apr, 2026
P/E koeffitsiyenti
25,55
52 haftalik eng yuqori
252,30Â SEK
52 haftalik eng past
175,90Â SEK
Aksiya boʻyicha daromad
9,82Â SEK
Muomaladagi aksiyalar
254,15Â mln
Xodimlar soni
12Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
TipRanks
·
4 soat oldin
Getinge Schedules Q3 2026 Report Release and Investor Call
AD HOC NEWS
·
1 kun oldin
Analysts lift fair value for Getinge stock to SEK 251.70
Profil
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
Getinge publ AB haqida